ASI is building a drug rescue platform to re-engineer promising drugs held back by cardiac safety. We design molecules to reduce cardiac risk while retaining therapeutic activity, then test them against the parent. Each program generates proprietary data, improves the engine and creates opportunities to license, sell or co-develop the resulting molecules.